Six hub genes (CXCL2, CXCL3, PTGDR2, GRP, CXCL11, and AGTR1) showed statistically different expression between the CRC and control samples and statistical correlation with the prognosis of CRC patients. This evidence concerns the gene GRP and colorectal carcinoma.